Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
TeraWulf reported second quarter 2026 results highlighting revenue growth with 102 MW of revenue-generating capacity at Lake Mariner and 336 MW under construction. The company secured a landmark 20-year, approximately $19 billion lease with Anthropic at its Kentucky Justified Data Campus and acquired the gigawatt-scale Muskie Data Campus. TeraWulf …
Astec Industries, Inc. reported its second quarter 2026 financial results with net sales rising 23.6% to $408.1 million and backlog increasing nearly 58%. Despite growth in Materials Solutions, delays in Infrastructure Solutions asphalt plant shipments caused a reduction in full-year adjusted EBITDA guidance from $170-$190 million to $160-$175 mill…
Atea Pharmaceuticals, a late-stage biopharmaceutical company developing oral antivirals for serious viral diseases, announced its Q2 2026 financial results call scheduled for August 12, 2026. The company continues to progress its Phase 3 hepatitis C program and Phase 1 hepatitis E study, sharing updates with investors.
Telix Pharmaceuticals Limited will host an R&D Day event in New York City on September 22, 2026, providing investors and analysts with a comprehensive update on its therapeutic and precision medicine pipeline. The event will feature presentations from company leadership and key opinion leaders, highlighting clinical, scientific, and strategic devel…
Hennessy Capital Investment Corp. VII (NASDAQ: HVII) and ONE Nuclear Energy LLC announced that the SEC has declared effective their registration statement, enabling a shareholder meeting on August 24, 2026, to approve their proposed business combination. Upon closing, ONE Nuclear Energy Inc. will become a publicly traded company on NASDAQ under the…
J & J Snack Foods Corp. reported its fiscal 2026 third quarter results with a 6.2% decline in net sales to $426 million, impacted mainly by reduced bakery and frozen beverage machine sales. Despite lower sales, gross profit rose slightly and gross margin expanded by 240 basis points to 35.5%, attributed to operational efficiencies under the Apollo …
Royalty Pharma plc announced robust second quarter 2026 results with 14% growth in Royalty Receipts to $768 million and an overall 6% increase in Portfolio Receipts to $773 million. The company raised its full-year 2026 portfolio receipts guidance to $3.4 to $3.5 billion driven by strong performance of key products and active investments in new roy…
Kaltura, Inc. announced strong second quarter 2026 results, surpassing revenue and adjusted EBITDA guidance. Subscription revenue grew 8% year-over-year to $45.6 million, with total revenue at $46.9 million. The company achieved record non-GAAP gross margin of 75% and its highest Q2 adjusted EBITDA to date at $5.9 million. Kaltura signed a record f…
Climb Global Solutions, Inc., a U.S.-based technology distributor, announced a distribution partnership with Harmonic Security to offer its AI governance platform to value-added resellers and managed service providers. This collaboration targets enhanced security for mid-market and enterprise adoption of AI, addressing risks from autonomous AI agen…
VisionWave Holdings, Inc. announced a planned acquisition of at least 51% of D-Fence Electronic Fencing Systems Ltd., an Israeli developer of AI-driven perimeter security technologies used in critical infrastructure worldwide. The transaction aims to build a comprehensive AI-powered defense platform by integrating D-Fence's solutions with VisionWav…
NewAmsterdam Pharma reported positive regulatory milestones, including a favorable CHMP opinion recommending marketing authorization for obicetrapib and its fixed-dose combination with ezetimibe in Europe. The company provided updates on ongoing Phase 3 cardiovascular and Alzheimer's disease trials, announced cash position of $678.3 million as of J…
BioCryst Pharmaceuticals reported robust Q2 2026 financial results with total net revenue of $218.3 million, an operating profit of $98.5 million, and maintained full-year ORLADEYO revenue guidance while raising total revenue outlook. Key milestones include starting shipments of ORLADEYO oral pellets for pediatric hereditary angioedema patients and…
Ascent Solar Technologies highlights its growing involvement in the expanding drone market alongside its core space industry applications. The company secured orders from satellite manufacturers and unmanned aerial and marine vehicle producers, showcasing its innovative thin-film photovoltaic technology that offers a superior power-to-weight ratio.…
Kymera Therapeutics reported Q2 2026 financial results highlighting rapid enrollment completion of their KT-621 Phase 2b trial in atopic dermatitis ahead of schedule, with topline data expected by year-end 2026. The company plans to initiate Phase 3 trials in mid-2027 and reported ongoing progress in multiple clinical programs addressing immunologi…
Sprott Inc. announced its Q2 2026 results with Assets Under Management (AUM) declining 15% from Q1 due to corrections in gold and silver prices. Despite this, average AUM grew 70% year over year, driven by strong inflows and market appreciation in critical materials products. Management fees increased by 72% year over year, while net income rose to…
Geron Corporation reported an 11% increase in net product revenue for its RYTELO (imetelstat) drug in Q2 2026 compared to Q1, reaching $57.5 million. The company reaffirmed its 2026 financial guidance, expecting RYTELO net product revenues between $220 million and $240 million. Geron expanded its leadership team, presented positive real-world effic…
Factorial Energy Inc., a US-based innovator in solid-state battery technology, announced its plans to attend the Oppenheimer Technology, Internet & Communications Conference and the J.P. Morgan Auto Conference in August 2026. The company highlighted its proprietary battery platforms backed by prominent industry and strategic investors and recent pe…
Entrada Therapeutics reported its second quarter 2026 financial results, highlighting strong progression in its clinical pipeline targeting neuromuscular diseases like Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1). Key clinical data readouts for their ENTR-601 program cohorts are expected between late 2026 and early 2027, al…
Seres Therapeutics announced second quarter 2026 financial results highlighting a net income of $4.6 million, driven by a $25 million milestone payment from Nestlé for the VOWST business sale. The company reported encouraging investigator-sponsored trial results for SER-155 in immune checkpoint inhibitor-related enterocolitis (irEC), showing 80% of…
Rapport Therapeutics reported Q2 2026 financial results and business updates, highlighting the initiation of two Phase 3 trials (FOCUS 1 and FOCUS 2) for RAP-219 in focal onset seizures. The company remains on track for topline Phase 2 results in bipolar mania later in 2026 and is progressing other pipeline candidates including a long-acting inject…
Tonix Pharmaceuticals, a commercial-stage biotech company focusing on CNS disorders, infectious diseases, immunology, and rare diseases, announced their upcoming participation in two investor conferences. Leadership will present company progress and pipeline developments, including marketed products TONMYA® for fibromyalgia and acute migraine treat…
Kamada Ltd., a global biopharmaceutical company specializing in specialty plasma-derived therapies and treatment for rare and serious conditions, announced it will release its second quarter and first half 2026 financial results on August 12, 2026, before U.S. markets open. The company will host a conference call to discuss results and provide upda…
GLOBALFOUNDRIES Inc. announced its preliminary Q2 2026 financial results, reporting revenue of $1.786 billion, surpassing guidance. The company demonstrated strong margin expansion and net income, driven by growing demand in AI data center solutions, semiconductor technology innovation, and strategic acquisitions. GF secured a $300 million governme…
DigitalOcean has pivoted from a developer-focused cloud to a cost-effective AI-native platform that is reeling in large enterprise inference commitments. Recent results and contract disclosures justify an upgrade to a tactical long: enter on a measured pullback, manage risk with a tight stop, and let the company’s contracted revenue and guidance ex…
Orion Energy Systems, Inc. reported a strong first quarter for fiscal 2027, with revenue increasing 32% year-over-year to $25.7 million, driven by growth across LED lighting, EV charging, and maintenance services. The company returned to profitability, achieving net income of $2 million and its seventh consecutive quarter of positive adjusted EBITD…
